Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2026-02-20 @ 1:33 AM
Study NCT ID:
NCT00860158
Status:
TERMINATED
Last Update Posted:
2018-03-14
First Post:
2009-03-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer
Sponsor:
Noah Hahn, M.D.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HOG GU07-124
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |